Corpus Christi, TX, United States of America

Theodore Horlenko


Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Houston, TX (US) (1981)
  • Corpus Christi, TX (US) (1976 - 1992)

Company Filing History:


Years Active: 1976-1992

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Theodore Horlenko

Introduction

Theodore Horlenko is a notable inventor based in Corpus Christi, Texas. He has made significant contributions to the field of chemistry, particularly in the production of acetaminophen. With a total of seven patents to his name, Horlenko's work has had a lasting impact on pharmaceutical manufacturing processes.

Latest Patents

Horlenko's latest patents focus on the production of N-acetyl-para-aminophenol, commonly known as acetaminophen. One of his innovative methods involves contacting 4-hydroxyacetophenone oxime with a Beckmann rearrangement catalyst in an alkyl alkanoate reaction solvent. This integrated process includes reacting 4-hydroxyacetophenone with a hydroxylamine salt and a base to obtain the oxime, which is then extracted and subjected to a Beckmann rearrangement. Additionally, he has developed a process that utilizes thionyl chloride as a catalyst, further enhancing the efficiency of acetaminophen production.

Career Highlights

Throughout his career, Theodore Horlenko has worked with prominent companies such as Celanese GmbH and Hoechst Celanese Corporation. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in chemical processes.

Collaborations

Horlenko has collaborated with esteemed colleagues, including John R. Fritch and James H. George. These partnerships have fostered a collaborative environment that has led to innovative solutions in their respective fields.

Conclusion

Theodore Horlenko's contributions to the field of chemistry, particularly in the production of acetaminophen, showcase his innovative spirit and dedication to advancing pharmaceutical processes. His patents and collaborations reflect a commitment to excellence in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…